XML 21 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-based Compensation
3 Months Ended
Mar. 31, 2018
Stock-based Compensation  
Stock-Based Compensation

6.Stock-Based Compensation

 

The Company maintains a stock incentive plan which authorizes the issuance of up to 442,750 shares of common stock. Of those shares, 18,168 were subject to outstanding options and 101,989 were reserved for future grants at March 31, 2018. The plan provides for grants of stock options or other stock awards to eligible participants, as described by the plan, at option prices ranging from 85% to 110% of fair market value at the date of grant.  Options granted expire up to seven years after the date of grant.  Such options generally become exercisable over a one- to three-year period.

 

The Company charged compensation cost of approximately $3,000 against income (loss) for the three months ended March 31, 2018 and $5,000 against income (loss) for the three months March 31, 2017.  As of March 31, 2018, there was approximately $14,000 of unrecognized compensation cost related to unvested share-based compensation awards granted. That cost is expected to be recognized over the next three years.

 

The Company receives a tax deduction for certain stock option exercises during the period in which the options are exercised, generally for the excess of the market price at the time the stock options are exercised over the exercise price of the options, which increases additional paid in capital and reduces income taxes payable.

 

No stock options were exercised during the three months ended March 31, 2018 or 2017, and there were no options granted during the three months ended March 31, 2018 or 2017.

 

Stock option activity during the three months ended March 31, 2018 was as follows:

 

 

 

 

 

 

 

 

    

 

    

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Exercise

 

 

    

Shares

    

Price

 

Outstanding at January 1, 2018

 

18,168

 

$

13.81

 

Outstanding at March 31, 2018

 

18,168

 

$

13.81

 

Exercisable at March 31, 2018

 

12,166

 

$

15.46

 

 

The aggregate intrinsic value of all options outstanding and exercisable at March 31, 2018 was  $0.